Epigenetics of hypertension as a risk factor for the development of coronary artery disease in type 2 diabetes mellitus

被引:3
|
作者
Karabaeva, Raushan Zh [1 ]
Vochshenkova, Tamara A. [1 ]
Mussin, Nadiar M. [2 ]
Albayev, Rustam K. [1 ]
Kaliyev, Asset A. [2 ]
Tamadon, Amin [3 ,4 ]
机构
[1] Presidents Affairs Adm Republ Kazakhstan, Med Ctr Hosp, Gerontol Ctr, Astana, Kazakhstan
[2] West Kazakhstan Marat Ospanov Med Univ, Gen Surg, Aktobe, Kazakhstan
[3] West Kazakhstan Marat Ospanov Med Univ, Dept Nat Sci, Aktobe, Kazakhstan
[4] PerciaVista R&D Co, Dept Res & Dev, Shiraz, Iran
来源
关键词
coronary artery disease; hypertension; type 2 diabetes mellitus; epigenetics; genetic variation; DNA methylation; histone; modification; DNA METHYLATION; BLOOD-PRESSURE; CARDIAC-HYPERTROPHY; LIFE-STYLE; GENE; MODULATION; EXPRESSION; SALT; PREECLAMPSIA; DEFICIENCY;
D O I
10.3389/fendo.2024.1365738
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypertension, a multifaceted cardiovascular disorder influenced by genetic, epigenetic, and environmental factors, poses a significant risk for the development of coronary artery disease (CAD) in individuals with type 2 diabetes mellitus (T2DM). Epigenetic alterations, particularly in histone modifications, DNA methylation, and microRNAs, play a pivotal role in unraveling the complex molecular underpinnings of blood pressure regulation. This review emphasizes the crucial interplay between epigenetic attributes and hypertension, shedding light on the prominence of DNA methylation, both globally and at the gene-specific level, in essential hypertension. Additionally, histone modifications, including acetylation and methylation, emerge as essential epigenetic markers linked to hypertension. Furthermore, microRNAs exert regulatory influence on blood pressure homeostasis, targeting key genes within the aldosterone and renin-angiotensin pathways. Understanding the intricate crosstalk between genetics and epigenetics in hypertension is particularly pertinent in the context of its interaction with T2DM, where hypertension serves as a notable risk factor for the development of CAD. These findings not only contribute to the comprehensive elucidation of essential hypertension but also offer promising avenues for innovative strategies in the prevention and treatment of cardiovascular complications, especially in the context of T2DM.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] Depression as a risk factor for coronary artery disease in Type I diabetes mellitus: A study of possible mechanisms
    Kinder, LS
    Orchard, TJ
    Wilson, R
    Kamarck, TW
    Lloyd, CE
    PSYCHOSOMATIC MEDICINE, 2000, 62 (01): : 106 - 107
  • [22] Diabetes mellitus Type 2: Coronary calcifications as a predictor of coronary artery disease
    Becker, A
    Knez, A
    Leber, A
    Boekstegers, P
    Steinbeck, G
    HERZ, 2004, 29 (05) : 488 - 495
  • [23] Prevalence of type 2 diabetes mellitus and risk of hypertension and coronary artery disease in rural and urban population with low rates of obesity
    Singh, RB
    Bajaj, S
    Niaz, MA
    Rastogi, SS
    Moshiri, M
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 1998, 66 (01) : 65 - 72
  • [24] Dietary patterns and risk of hypertension, type 2 diabetes mellitus, and coronary heart disease.
    Schulze M.B.
    Hu F.B.
    Current Atherosclerosis Reports, 2002, 4 (6) : 462 - 467
  • [25] Chronic kidney disease as a risk factor for coronary artery disease in Chinese with type 2 diabetes
    Hsieh, Ming-Chia
    Hsiao, Jeng-Yueh
    Tien, Kai-Jen
    Chang, Shun-Jen
    Hsu, Shih-Chieh
    Liang, Hui-Ting
    Chen, Hung-Chun
    Lin, Shiu-Ru
    Tu, Shih-Te
    AMERICAN JOURNAL OF NEPHROLOGY, 2008, 28 (02) : 317 - 323
  • [26] Identification of Risk Factors for Coronary Artery Disease in Asymptomatic Patients with Type 2 Diabetes Mellitus
    Takamura, Kazuhisa
    Fujimoto, Shinichiro
    Mita, Tomoya
    Kawaguchi, Yuko Okano
    Kurita, Mika
    Kadowaki, Satoshi
    Kamo, Yuki
    Aoshima, Chihiro
    Nozaki, Yui Okada
    Takahashi, Daigo
    Kudo, Ayako
    Hiki, Makoto
    Tomizawa, Nobuo
    Ikeda, Fuki
    Satoh, Hiroaki
    Watada, Hirotaka
    Minamino, Tohru
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (05)
  • [27] Silent coronary artery disease in patients with type 2 diabetes mellitus
    Gokcel, A
    Aydin, M
    Yalcin, F
    Yapar, AF
    Ertorer, ME
    Ozsahin, AK
    Muderrisoglu, H
    Aktas, A
    Guvener, N
    Akbaba, M
    ACTA DIABETOLOGICA, 2003, 40 (04) : 176 - 180
  • [28] Metabolomic Signature of Coronary Artery Disease in Type 2 Diabetes Mellitus
    Stratmann, Bernd
    Richter, Katrin
    Wang, Ruichao
    Yu, Zhonghao
    Xu, Tao
    Prehn, Cornelia
    Adamski, Jerzy
    Illig, Thomas
    Tschoepe, Diethelm
    Wang-Sattler, Rui
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2017, 2017
  • [29] Genetic Predisposition to Coronary Artery Disease in Type 2 Diabetes Mellitus
    van Zuydam, Natalie R.
    Ladenvall, Claes
    Voight, Benjamin F.
    Strawbridge, Rona J.
    Fernandez-Tajes, Juan
    Rayner, N. William
    Robertson, Neil R.
    Mahajan, Anubha
    Vlachopoulou, Efthymia
    Goel, Anuj
    Kleber, Marcus E.
    Nelson, Christopher P.
    Kwee, Lydia Coulter
    Esko, Tonu
    Mihailov, Evelin
    Magi, Reedik
    Milani, Lili
    Fischer, Krista
    Kanoni, Stavroula
    Kumar, Jitender
    Song, Ci
    Hartiala, Jaana A.
    Pedersen, Nancy L.
    Perola, Markus
    Gieger, Christian
    Peters, Annette
    Qu, Liming
    Willems, Sara M.
    Doney, Alex S. F.
    Morris, Andrew D.
    Zheng, Yan
    Sesti, Giorgio
    Hu, Frank B.
    Qi, Lu
    Laakso, Markku
    Thorsteinsdottir, Unnur
    Grallert, Harald
    van Duijn, Cornelia
    Reilly, Muredach P.
    Ingelsson, Erik
    Deloukas, Panos
    Kathiresan, Sek
    Metspalu, Andres
    Shah, Svati H.
    Sinisalo, Juha
    Salomaa, Veikko
    Hamsten, Anders
    Samani, Nilesh J.
    Maerz, Winfried
    Hazen, Stanley L.
    CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2020, 13 (06): : 640 - 648
  • [30] Screening for asymptomatic coronary artery disease in type 2 diabetes mellitus
    Bacus, H. B.
    Motala, A. A.
    Pirie, F. J.
    JOURNAL OF ENDOCRINOLOGY METABOLISM AND DIABETES OF SOUTH AFRICA, 2008, 13 (01) : 14 - 17